A search at (using keywords GLP-1 and cardiovascular) returns 36 open studies, which hints towards an increasing interest in the cardiovascular effects of incretin based therapies
Being aware of what is in your specific formulation helps explain any unexpected lab findings
Based on preclinical studies, a systematic review of the neuroprotective mechanisms of GLP-1RA-based therapy in ischemic stroke [67] has shown that administration of drugs of this family before, during, or after an experimental stroke in animals with and without diabetes modulates an acute inflammatory response secondary to brain ischemia, reducing inflammation, endothelial dysfunction and excitotoxicity, as well as decreasing oxidative stress and apoptosis
GLP-1 medications are not recommended for use during pregnancy
Furthermore, incorporating regular resistance training (not just cardio) is vital
This review covers the development and clinical efficacy of various GLP-1-based therapeutics, exploring the challenges and future directions in obesity management